Case # 53 presented by Mourad Mansourian. Summary Case 53 Patient 32 yr. old male attended funeral...
-
Upload
dustin-whitehead -
Category
Documents
-
view
215 -
download
0
Transcript of Case # 53 presented by Mourad Mansourian. Summary Case 53 Patient 32 yr. old male attended funeral...
Case # 53presented
by
Mourad Mansourian
Summary Case 53Patient 32 yr. old male attended funeral in Haiti.4 days later developed temp. 39.5°C, myalgia, constipation After 3-weeks history of fever, nausea, vomiting, diarrhea (6 watery stool/day), dark urine.Hospitalized with
Temp 37.7°CBlood pressure 115/75 mm HgPulse 104 b/min.
Passed out while walking to bathroomI.V. CefotaximeDischarged on oral Cefotaxime.Symptoms recurred 2 weeks later.
Green: Sporadic outbreaksOrange : Medium endemicity
Yellow: High endemicity
Traveled to 3rd world country.Attended Haitian funeral-unembalmed bodies (customary food and drinks served-etiologic agent)Started with constipation rather than diarrhea (common S. typhi infection)Developed
fever 39.5°C six watery diarrhea per dayNausea and vomitingdehydrationLow blood pressure (dizziness-fainted in the hospital) Supine pulse 104 b/min
Blood and stool culture positive
Key information pointing to diagnosis
Drumming, food and drink last for days
Classifications Gram negative rods Motile Encapsulated Facultative anaerobic Non sporing Growth MacConkey non lactose fermenting
smooth colonies Growth on BA non hemolytic white colonies TSI K/A H2S no gas
Pathogenesis Ingest organism via contaminated food or water Organism resists gastric acid Reaches the proximal end of small intestine Invades & penetrates intestinal mucosa (at this
time patient experience constipation rather than diarrhea)
Gains entrance into the lymph nodes Reaches the blood stream Spreads to the liver, spleen, and bone marrow Engulfed by mononuclear phagocytes
Salmonella invasion of epithelial cells
Pathogenesis
Pathogenesis continued
Multiply intracellularly Released into blood stream for 2nd time Febrile episode more evident (now can be
isolated from blood) Invades gall bladder and Peyer’s patches of the
bowel Reach the intestinal tract via billary tract,
initiates GI symptoms (diarrheal stage) Gall bladder becomes foci for long term
carriage of the organisms (now can be isolated from stool)
S. typhiElectron microscopy Flagellar stain
Virulence factors Subject to speculation and still remain uncertain Role of fimbriae has been cited
Fimbriated strains are more virulent than non-fimbriated
Ability to traverse intestinal mucosa Factors that mediate this mechanism have not been
established
Enterotoxin production by certain strains that cause gastroenteritis implicated as virulent vactor
Diagnosis Definitive diagnosis is isolation of S. typhi from
blood, bone marrow, urine or specific anatomic lesion
*Blood culture is the mainstay of diagnosis* Presence of clinical symptoms of typhoid fever
or detection of specific antibody response is suggestive but not definitive (Widal test 4-fold rise in titer between acute and convalescent stage)
Stool culture useful for diagnosis of typhoid carriers
Identification Blood agar-non hemolytic white colonies MacConkey-non lactose fermenting
smooth coloniesSS agar-black center with clear
edges Biochemistry
• TSI K/A H2S (gas small amount) • LIA K/K H2S • Urea –• Motility +• Citrate +/-• Indole - SS agar
Treatment
Should be based on antibiotic susceptibility of patient’s culture
Fluoroquinolones drug of choice Commonly used drugs Sulfonamides, Streptomycin,
Tetracycline, Cefotaxime, Ampicillin, and Chloramphenicol
Diarrheal stage replace lost fluid Chronic colonization of gallbladder-persistent
shedding of the organisms ”Typhoid Mary” remove gallbladder
Once asymptomatic and after three 24 hr apart consecutive negative stool cultures, may return to work
PreventionNo typhoid vaccine is 100% effective.
Food and drink precautions
vaccine type Vaccine name
How given
Number of doses
Time between doses
Min. age Booster need every
Oral attenuated
TY21a Capsule by mouth
Four Two days
six years old
Five years
Capsular polysacch.
ViCPS Injection One N/A Two years old
Two years
Primary research article contributing to the preventing of disease caused by S. typhi
Guzman C. et al. 2006, Vaccine against typhoid fever. Vaccine, 24(18) 3804-11
Purpose To activate cell mediated immune response, post vaccination of CVD
909 derived from strains of CVD 908-htrA Method
Group one vaccinated with a single dose of CVD-909 Group two vaccinated with double dose
Results CVD 909 is immunogenic after one or two doses, as the parent strain or
the licensed Ty21a vaccines which confers moderate protection following 3-4 doses.
Conclusion The second immunization dose did not enhance the lymphopolifiration
response Single dose vaccination is enough
Result cont’d. Response to vaccination with a single and a double dose of CVD 909
References• Guzman c, Borsutzky S, Griot-Wenk M, Metcalfe IC, Pearman J, Collioud A,
Favre D, Dietric G. Vaccines against typhoid fever 2006. Vaccine 24(18) 3804-11
• Chaicumpa W, Ruangkunaporin Y, Bur D, Chungsa-Nguan M, Echeveria P. Diagnosis of typhoid fever by detection of S. typhi antigen in urine 2000. J clinical Microbiol 30(9): 2513-5
• Ansong c, Yoon H, Norbeck A, Gustin J, McDermott J, Mottaz HM, Rue J, Adkin J, HeffronF, Smith,D. Proteomics analysis of the causitive agent of typhoid fever 2008. J. Proteo Res 7(2) 546-7
• House D, Bishop A, Parry C, Dougen G, WeinJ. Typhoid fever: Pathogenesis and disease 2001. Infect Dis 14: 573-8